To characterise the gene transition patterns associated with p53 inactivation‐driven heterogeneity in tumours, we analysed changes in hallmark gene sets of recurrent malignancy heterogeneity previously identified in pan‐cancer samples48(Figures 3E–H and S12). This evidence concerns the gene TP53 and cancer.